Genomic HLA-DRB1 matching further improves clinical course after renal transplantation.
Leivestad
T
T
Surgical Department B, National Hospital, Oslo, Norway.
Spurkland
A
A
Knutsen
I
I
Bratlie
A
A
Vartdal
F
F
Pfeffer
P
P
Sødal
G
G
Fauchald
P
P
Thorsby
E
E
D000206:Actuarial Analysis; D000704:Analysis of Variance; D005802:Genes, MHC Class II; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006085:Graft Survival; D006684:HLA-DR Antigens / Q000235:genetics*; D059811:HLA-DRB1 Chains; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests; D011379:Prognosis; D012044:Regression Analysis; D012189:Retrospective Studies; D015996:Survival Rate
D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains